as per atttachment

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.4%Reaction day

₹76.17

prior close

₹79.95

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.6%+1.8% vs market

Healthcare Service Provider peers, median of 23sector+1.2%+1.3% vs sector

On the reaction day the stock moved 1.8 pts more than Nifty Microcap 250 and 1.3 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.1

15m

-0.1

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.4+0.6+1.8+1.2+1.3

Next day

+4.9+0.5+4.4+0.2+4.7

+3.6+0.8+2.8+0.1+3.5

+2.4+1.2+1.2+0.5+1.9

+3.7+1.5+2.2-0.3+4.0

+3.4+1.6+1.8-1.1+4.5

+3.7+1.8+1.9-0.7+4.4

15d

+2.1+3.3-1.1+4.1-1.9

+4.8+3.1+1.7+1.8+3.0

+0.6+2.3-1.7+7.8-7.2

+152.7+0.2+152.5+11.2+141.5

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sharma East India Hospitals reported strong full-year FY25 results with total revenue rising to ₹30.19 crore, up about 27% from ₹23.83 crore in FY24. Profit after tax jumped to ₹1.24 crore from ₹66.30 lakh, nearly doubling year-on-year, while EPS improved to ₹3.79 from ₹2.02. For Q4 alone, revenue dipped to ₹6.22 crore from ₹7.11 crore a year earlier, but the company remained profitable. Operating cash flow turned strongly positive at ₹6.69 crore versus a negative ₹1.13 crore last year, and short-term borrowings fell sharply from ₹3.87 crore to ₹1.09 crore. Statutory auditors Gopal Sharma & Co issued an unmodified (clean) opinion on the results.

Likely market impact

The sharp rise in full-year profits, cleaner balance sheet with reduced debt, and swing to positive operating cash flow are positive signals for shareholders. However, the Q4 revenue decline and small absolute profit base mean the stock may see limited excitement despite the strong annual numbers.